The Cochrane Collaboration
Cochrane Reviews
Explore New + Updated Other languages
Full Text:  The Cochrane Library
search & browse | by topic | full list of all reviews | by country of author | by date range

by Topic (Review Group):

Browse by topic (Review Group) - For sub-topics (only reviews + protocols), click here


View stages (what is this?): all titles Titles protocol Protocols review Reviews

Acetyl-l-carnitine for dementia
Acupuncture for vascular dementia
Almitirine-Raubasine combination for dementia (title stage)
Updated
Alpha lipoic acid for dementia
Antiandrogenic treatment for sexual disinhibition in male patients with dementia (protocol stage)
Antibiotics for dementia and mild cognitive impairment (title stage)
Antidepressants for treating depression in dementia
Antipsychotics for delirium
Aroma therapy for dementia
Aspirin and anti-inflammatory drugs for Alzheimer's disease (protocol stage)
Updated
Aspirin for vascular dementia
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
Benzodiazepines for delirium (protocol stage)
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
Caffeine for cognition (protocol stage)
Cannabinoids for the treatment of dementia (protocol stage)
Carbamazepine and oxcarbazepine for the treatment of behavioural and psychological symptoms of dementia (BPSD) (title stage)
Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment (protocol stage)
Case/care management approaches to home support for people with dementia (title stage)
Cerebrolysin for Alzheimer's disease (protocol stage)
Cholinesterase inhibitors and memantine for analysis of deaths in vascular dementia and Alzheimer's disease (title stage)
Cholinesterase inhibitors for Alzheimer's disease
Cholinesterase inhibitors for delirium
Cholinesterase inhibitors for dementia with Lewy bodies
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease (protocol stage)
Cholinesterase inhibitors for Parkinson's disease dementia
Cognition-based interventions for older people and people with mild cognitive impairment (protocol stage)
withdrawn
Cognition-based interventions for people with Mild Cognitive Impairment (protocol stage)
Cognitive and behavioural interventions for carers of people with dementia (protocol stage)
Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia
Cognitive stimulation to improve cognitive functioning in people with dementia (protocol stage)
Coordinated care interventions for the management of delirium in hospitalized patients (protocol stage)
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly
D-cycloserine for Alzheimer's disease
withdrawn
Dehydroepiandrosterone (DHEA) supplementation for cognitive function
Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people
Donepezil for dementia due to Alzheimer's disease
Donepezil for mild cognitive impairment
Donepezil for vascular dementia
Driving assessment for maintaining mobility and safety in drivers with dementia (protocol stage)
Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia
Enteral feeding for older people with advanced dementia (protocol stage)
withdrawn
Eptastigmine for dementia due to Alzheimer's disease (protocol stage)
Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people
Functional analysis-based interventions for challenging behaviour in dementia (protocol stage)
Galantamine for Alzheimer's disease and mild cognitive impairment
Galantamine for vascular cognitive impairment
Ginkgo biloba for cognitive impairment and dementia
Ginkgo biloba for cognitive improvement in healthy individuals (protocol stage)
Ginseng for dementia (title stage)
Haloperidol for agitation in dementia
Homeopathy for dementia
Hormone replacement therapy for cognitive function in postmenopausal women
Hormone replacement therapy to maintain cognitive function in women with dementia
Huperzine A for Alzheimer's disease
New
Huperzine A for vascular dementia (protocol stage)
Hydergine for dementia
Ibuprofen for Alzheimer's disease
Indomethacin for Alzheimer's disease
Information and support interventions for informal caregivers of people with dementia (protocol stage)
Interventions for preventing and reducing the use of physical restraints in long-term geriatric care (title stage)
Interventions for preventing delirium in hospitalised patients
Lecithin for dementia and cognitive impairment
Light Therapy for Managing Sleep, Behaviour, and Mood Disturbances in Dementia
Massage and touch for dementia
Updated
Melatonin for cognitive impairment
Memantine for dementia
Metal protein attenuating compounds for the treatment of Alzheimer's disease
Metrifonate for Alzheimer's disease
withdrawn
Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment
Music therapy for people with dementia
Naftidrofuryl for dementia (protocol stage)
withdrawn
Naproxen for Alzheimer's disease (protocol stage)
Nicergoline for dementia and other age associated forms of cognitive impairment
Nicotine for Alzheimer's disease
Nimodipine for primary degenerative, mixed and vascular dementia
Non-pharmacological interventions for wandering of people with dementia in the domestic setting
Omega 3 fatty acid for the prevention of dementia
Passive Abeta immunisation for the treatment of Alzheimer's disease (title stage)
withdrawn
Pharmacological interventions for sleep disorder in people with dementia (protocol stage)
Pharmacotherapy for cognitive impairment in traumatic brain injury (title stage)
Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment
Physical activity for improving cognition in older people with mild cognitive impairment (title stage)
Physical activity programs for persons with dementia
Updated
Physostigmine for dementia due to Alzheimer's disease
Piracetam for dementia or cognitive impairment
New
Posatirelin (l-pyro-2-aminoadipyl-l-leucyl-l-prolinamide) treatment for persons with dementia (protocol stage)
New
Procaine treatments for cognition and dementia
Propentofylline for dementia
withdrawn
Reality orientation for dementia
Reminiscence therapy for dementia
Respite care for people with dementia and their carers
Rivastigmine for Alzheimer's disease
Rivastigmine for vascular cognitive impairment
Selegiline for Alzheimer's disease
Shunting for normal pressure hydrocephalus (NPH)
Snoezelen for dementia
Special care units for dementia individuals with behavioural problems (protocol stage)
Statins for the prevention of Alzheimer's disease and dementia
Statins for the treatment of Alzheimer's disease and dementia (title stage)
Subjective barriers to prevent wandering of cognitively impaired people
withdrawn
Support for carers of people with Alzheimer's type dementia
withdrawn
Tacrine for Alzheimer's disease
Testosterone supplementation for mild cognitive impairment and dementia (title stage)
withdrawn
The effect of cholinesterase inhibitors on the risk of falls and injuries in patients with mild to moderate Alzheimer's dementia (protocol stage)
Thiamine for Alzheimer's disease
Updated
Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse
Thiazolidinediones for dementia and mild cognitive impairment (title stage)
Thioridazine for dementia
Tramiprosate (Alzhemed) for Alzheimer's disease (title stage)
Transcutaneous Electrical Nerve Stimulation (TENS) for dementia
Trazodone for agitation in dementia
Validation therapy for dementia
Valproate preparations for agitation in dementia
Velnacrine for Alzheimer's disease
Vinpocetine for cognitive impairment and dementia
Vitamin B12 for cognition
Vitamin B6 for cognition
Vitamin E for Alzheimer's disease and mild cognitive impairment
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and neuropsychiatric symptoms in elderly patients with dementia (title stage)
Yizhi capsule for vascular dementia
Zhiling decoction for vascular dementia